As part of our commitment to stakeholder engagement, CADTH is inviting patient advocacy groups, clinicians, pharmaceutical manufacturers, associations, and consultants to attend an information and feedback session on the transition of pCODR to CADTH.
The purpose of the sessions will be to:
The discussion panellists from CADTH will include:
CADTH is hosting two separate sessions — one for patient advocacy groups and clinicians, and another for pharmaceutical manufacturers, associations, and consultants.
Delta Meadowvale Hotel and Conference Centre
6750 Mississauga Road
|Patient Advocacy Groups
|Pharmaceutical Manufacturers, Associations, and Consultants|
|Thursday, February 5, 2015||Thursday, February 5, 2015|
|9:30 a.m. to 11:30 a.m. EST||2:00 p.m. to 4:00 p.m. EST|
A teleconference option will be provided for individuals or organizations unable to join us in person.